國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Helicobacter pylori

Marshall, Barry.

Helicobacter pylori

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Helicobacter pyloriedited by Hidekazu Suzuki, Robin Warren, Barry Marshall.
其他作者:	Suzuki, Hidekazu.
出版者:	Tokyo :Springer Japan :2016.
面頁冊數:	x, 267 p. :ill. (some col.), digital ;24 cm.
Contained By:	Springer eBooks
標題:	Helicobacter pylori.
電子資源:	http://dx.doi.org/10.1007/978-4-431-55705-0
ISBN:	9784431557050$q(electronic bk.)

Helicobacter pylori
Helicobacter pylori[electronic resource] /edited by Hidekazu Suzuki, Robin Warren, Barry Marshall. - Tokyo :Springer Japan :2016. - x, 267 p. :ill. (some col.), digital ;24 cm.

Part I History -- Chapter 1 Brief History of the Discovery of Helicobacter Pylori -- Part II Pathogenesis -- Chapter 2 Human Migration -- Chapter 3 CagA -- Chapter 4 Helicobacter Pylori VacA Exhibits Pleiotropic Actions in Host Cells -- Chapter 5 Autophagy -- Chapter 6 Ghrelin and Gut Hormone -- Chapter 7 Symptom Generation -- Chapter 8 Gastric Non-Helicobacter Pylori Helicobacter: It's Significance in Human Gastric Diseases -- Part III Diagnosis -- Chapter 9 Urea Breath Test & Rapid Urease Test -- Chapter 10 Endoscopic Findings of H. Pylori Infection -- Chapter 11 Gastric Cancer Risk stratification by H. pylori -- Chapter 12 Prevention of Gastric Cancer by Helicobacter Pylori Eradication: Current Evidence and Future Prospects -- Part IV Treatment -- Chapter 13 Trends in Global Eradication Rates -- Chapter 14 Personalized Therapy in H. Pylori Eradication -- Chapter 15 Quadruple Regimens for Helicobacter Pylori Infection -- Chapter 16 Third-Line Eradication Therapy.

This book provides a detailed review of the most recent pathogenetic, diagnostic and therapeutic approaches in connection with Helicobacter pylori, along with priority areas in research and trends in clinical practice to address this significant pathogen acknowledged as the causative agent in a wide range of diseases, including gastric adenocarcinoma, MALT lymphoma and immune thrombocytopenic purpura (ITP) Medical authorities worldwide now recommend a "test and treat" strategy for this bacterial infection. Eradication therapy approaches range from general mass eradication therapy to tailor-made therapy for antibiotic-resistant refractory infection. In regions with high prevalence of H. pylori infection, the infection itself would be considered a major parameter to predict the risk of gastric adenocarcinoma development. The main interest has shifted recently to the risk stratification strategy for gastric cancer development and to the wide-ranging application of its serological prevention program. This book will benefit all gastroenterologists, hematologists, dermatologists, primary care doctors, epidemiologists, physicians who related with community hygiene, as well as basic scientists, particularly microbiologists, bacteriologists, pathologists, molecular biologists, biochemists, immunologists and oncologists.

ISBN: 9784431557050$q(electronic bk.)

Standard No.: 10.1007/978-4-431-55705-0doiSubjects--Topical Terms:

745197
Helicobacter pylori.

LC Class. No.: QR201.H44

Dewey Class. No.: 616.92

Helicobacter pylori
LDR:03245nmm a2200313 a 4500 001 486896
003 DE-He213
005 20160930114659.0
006 m d
007 cr nn 008maaau
008 161116s2016 ja s 0 eng d
020 $a 9784431557050$q(electronic bk.)
020 $a 9784431557043$q(paper)
024 7 $a 10.1007/978-4-431-55705-0 $2 doi
035 $a 978-4-431-55705-0
040 $a GP $c GP
041 0 $a eng
050 4 $a QR201.H44
072 7 $a MJH $2 bicssc
072 7 $a MED031000 $2 bisacsh
082 0 4 $a 616.92 $2 23
090 $a QR201.H44 $b H475 2016
245 0 0 $a Helicobacter pylori $h [electronic resource] / $c edited by Hidekazu Suzuki, Robin Warren, Barry Marshall.
260 $a Tokyo : $b Springer Japan : $b Imprint: Springer, $c 2016.
300 $a x, 267 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a Part I History -- Chapter 1 Brief History of the Discovery of Helicobacter Pylori -- Part II Pathogenesis -- Chapter 2 Human Migration -- Chapter 3 CagA -- Chapter 4 Helicobacter Pylori VacA Exhibits Pleiotropic Actions in Host Cells -- Chapter 5 Autophagy -- Chapter 6 Ghrelin and Gut Hormone -- Chapter 7 Symptom Generation -- Chapter 8 Gastric Non-Helicobacter Pylori Helicobacter: It's Significance in Human Gastric Diseases -- Part III Diagnosis -- Chapter 9 Urea Breath Test & Rapid Urease Test -- Chapter 10 Endoscopic Findings of H. Pylori Infection -- Chapter 11 Gastric Cancer Risk stratification by H. pylori -- Chapter 12 Prevention of Gastric Cancer by Helicobacter Pylori Eradication: Current Evidence and Future Prospects -- Part IV Treatment -- Chapter 13 Trends in Global Eradication Rates -- Chapter 14 Personalized Therapy in H. Pylori Eradication -- Chapter 15 Quadruple Regimens for Helicobacter Pylori Infection -- Chapter 16 Third-Line Eradication Therapy.
520 $a This book provides a detailed review of the most recent pathogenetic, diagnostic and therapeutic approaches in connection with Helicobacter pylori, along with priority areas in research and trends in clinical practice to address this significant pathogen acknowledged as the causative agent in a wide range of diseases, including gastric adenocarcinoma, MALT lymphoma and immune thrombocytopenic purpura (ITP) Medical authorities worldwide now recommend a "test and treat" strategy for this bacterial infection. Eradication therapy approaches range from general mass eradication therapy to tailor-made therapy for antibiotic-resistant refractory infection. In regions with high prevalence of H. pylori infection, the infection itself would be considered a major parameter to predict the risk of gastric adenocarcinoma development. The main interest has shifted recently to the risk stratification strategy for gastric cancer development and to the wide-ranging application of its serological prevention program. This book will benefit all gastroenterologists, hematologists, dermatologists, primary care doctors, epidemiologists, physicians who related with community hygiene, as well as basic scientists, particularly microbiologists, bacteriologists, pathologists, molecular biologists, biochemists, immunologists and oncologists.
650 0 $a Helicobacter pylori. $3 745197
650 0 $a Helicobacter pylori infections. $3 745198
650 1 4 $a Medicine & Public Health. $3 273799
650 2 4 $a Gastroenterology. $3 274091
650 2 4 $a Pathology. $3 196513
650 2 4 $a Hematology. $3 274899
700 1 $a Suzuki, Hidekazu. $3 745194
700 1 $a Warren, Robin. $3 745195
700 1 $a Marshall, Barry. $3 745196
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-4-431-55705-0
950 $a Medicine (Springer-11650)